Method and apparatus for the fail-safe termination of in vivo drug delivery from an implantable drug delivery system

Patent metadata

Field	Value
Publication number	US-12337141-B2
Application number	US-202318388626-A
Country	US
Kind code	B2
Filing date	Nov 10, 2023
Priority date	Oct 19, 2015
Publication date	Jun 24, 2025
Grant date	Jun 24, 2025

Abstract

A method for the fail-safe termination of in vivo drug delivery from an implantable drug delivery system, the method comprising: providing an implantable drug delivery system comprising: a housing having a reservoir for containing a drug, and a port for dispensing the drug to a patient; and an emergency deactivation unit disposed between the reservoir and the port, the emergency deactivation unit comprising a composite structure comprising a biocompatible ferromagnetic mesh open to fluid flow and a hydrophobic meltable material, the hydrophobic meltable material comprising at least one hole therein for enabling a fluid to pass through the hydrophobic meltable material; implanting the implantable drug delivery system within a patient; enabling the drug to flow from the reservoir, through the at least one hole in the hydrophobic meltable material and out the port; and when drug flow is to be terminated, applying a magnetic field to the composite structure, such that a current is induced in the ferromagnetic mesh which heats the ferromagnetic mesh and melts the hydrophobic meltable material, thereby closing the at least one hole in the hydrophobic meltable material and blocking drug delivery to the patient.

First claim

That is claimed is:

1. A method for fail-safe termination of fluid flow through a fluid pathway, the method comprising:
providing an emergency deactivation unit comprising: a barrier element positioned along the fluid pathway and comprising a hydrophobic material having a solid state at physiological temperature and a flowable state above physiological temperature, the barrier element comprising an opening extending therethrough for allowing fluid to pass through the barrier element;
implanting the emergency deactivation unit within a patient;
enabling fluid to flow from one side of the emergency deactivation unit, through the opening in the barrier element, to the other side of the emergency deactivation unit; and
when fluid flow is to be terminated, increasing the temperature of the barrier element, causing the hydrophobic material of the barrier element to flow, whereby to close the opening in the barrier element and block fluid flow through the fluid pathway.

2. A method according to claim 1 , further comprising positioning the emergency deactivation unit at a beginning or an end of the fluid pathway.

3. A method according to claim 1 , further comprising positioning the emergency deactivation unit at a middle portion of the fluid pathway.

4. A method according to claim 1 , further comprising positioning the emergency deactivation unit at a branching section of the fluid pathway.

5. A method according to claim 1 , wherein the fluid pathway comprises an implantable capsule.

6. A method according to claim 1 , wherein the fluid pathway comprises a tube fluidly coupled to a pump.

7. A method according to claim 1 , wherein the emergency deactivation unit comprises a reservoir containing a drug, and wherein the barrier element is positioned to terminate flow of the drug to a body of the patient.

8. A method according to claim 1 , wherein the temperature of the barrier element is increased based on activation from outside of a body of the patient.

9. A method according to claim 1 , wherein the emergency deactivation unit comprises a rate-limiting membrane positioned to control the fluid flow through the opening of the barrier element.

10. Apparatus for fail-safe termination of fluid flow through a fluid pathway, the apparatus comprising:
an implantable emergency deactivation unit comprising: a barrier element comprising a hydrophobic material having a solid state at physiological temperature and a flowable state above physiological temperature, the barrier element comprising an opening extending therethrough for allowing fluid to pass through the barrier element;
wherein appropriately increasing the temperature of the barrier element when the emergency deactivation unit is implanted in a patient causes the hydrophobic material of the barrier element to flow, whereby to close the opening in the barrier element and block fluid flow through the fluid pathway.

11. Apparatus according to claim 10 , wherein the implantable emergency deactivation unit comprises a rate-limiting membrane overlapping the opening of the barrier element.

12. Apparatus according to claim 10 , wherein the physiological temperature ranges between about 30 degrees Celsius (° C.) and about 45° C.

13. A method for manufacturing apparatus for fail-safe termination of fluid flow through a fluid pathway, the method comprising:
providing a substrate comprising a hydrophobic material having a solid state at physiological temperature and a flowable state above physiological temperature;
positioning a heating element on the substrate;
positioning, atop the substrate and the heating element, a cover comprising a hydrophobic material having a solid state at physiological temperature and a flowable state above physiological temperature; and
adhering the cover to the substrate and forming an opening through the cover and the substrate adjacent to the heating element to produce an implantable emergency deactivation unit that enables selective termination of fluid flow through the opening when the emergency deactivation unit is implanted in a patient.

14. A method according to claim 13 , wherein the hydrophobic material of the substrate, and the hydrophobic material of the cover, both comprise polycaprolactone.

15. A method according to claim 13 , wherein the heating element comprises a magnetic heating element adapted to increase in temperature when exposed to a magnetic field.

16. A method according to claim 15 , wherein the magnetic heating element comprises a ferromagnetic mesh.

17. A method according to claim 15 , wherein the magnetic heating element comprises ferromagnetic powder or shavings.

18. A method according to claim 13 , further comprising fluidly coupling the opening to a reservoir containing a drug to be dispensed to the patient.

19. A method according to claim 13 , further comprising positioning the emergency deactivation unit within an implantable capsule or device.

Assignees

• Methodist Hospital

Inventors

• Farina Marco
• Hood Robert Lyle
• Grattoni Alessandro

Classifications

• A61M2207/00

  Methods of manufacture, assembly or production · CPC title

• A61M2205/3523

  using telemetric means · CPC title

• A61M2205/0288

  Electro-rheological or magneto-rheological materials · CPC title

• A61M2205/02

  characterised by a particular materials · CPC title

• A61M5/14276

  specially adapted for implantation · CPC title